Antibody induced T cell-mediated neonatal autoimmunity.

抗体诱导 T 细胞介导的新生儿自身免疫。

基本信息

  • 批准号:
    7743774
  • 负责人:
  • 金额:
    $ 37.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-12-15 至 2012-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is the competitive renewal application to extend our work supported by AI51420-01 A. Significant progress has been made that greatly elucidate the mechanism of the unique neonatal autoimmune ovarian disease (nAOD). Autoantibody (Ab) to the ovarian ZP3 led to the formation of ovarian immune complex. This provokes an organ specific autoimmune disease that is regulated by FcgR+, and dependent on de novo activation of pathogenic CD4 T cells (TD-nAOD). Uniquely, nAOD affects only neonatal mice and spares mice beyond 5 days of age; therefore, the understanding neonatal propensity to autoimmunity is our major goal. We discovered that severe nAOD is also induced in the recombinase activating gene (RAG) knockout (KO) mice, thus innate immunity alone is also sufficient to induce nAOD (TI-nAOD). NK cells play multiple and pivotal roles in TI-nAOD. A seminal observation is the ontogenetic regulation of NK cell function in TI- nAOD. RAG KO mice deficient in perforin did not develop TI-nAOD, and the disease was restored by neonatal but not adult (or day 9) NK cells from wild type donors. NK function in TI-nAOD also depended on NKG2D - a major NK cell activating receptor. In AIM 1, we will test the hypothesis that the late ontogeny of expression of the Ly49 NK cell inhibitory receptors allows neonatal NK cells to escape from regulation between neonatal 1-5 days, and to induce neonatal ovarian injury. The pro-inflammatory cytokine IFNg and also FcgR played non-redundant roles in the pathogenesis of both TI-nAOD and TD-nAOD. In AIM 2, we will investigate the cellular basis for the IFNg- and NK cell- dependent functions in TI-nAOD of RAG KO mice. And in AIM 3, we will investigate how neonatal NK cells and IFNg promote de novo pathogenic T cell responses in TD-nAOD of wild type mice; in particular, determine the relative contribution of NK cells and dendritic cells in this process. Finally, the NK cell-dependent TI-nAOD was readily suppressed by adult CD4+CD25+ Treg, and it requires IL10. This finding documents, for the first time, Treg suppression of any form of neonatal immune response. In AIM 4, we will investigate the cellular mechanism of the IL10- dependent Treg suppression. Also, by comparing the mechanism of suppression between the adult and the neonatal hosts, we expect to obtain new insight into the physiology of neonatal immune system, and further elucidate the important observation of neonatal propensity to autoimmune disease.
描述(由申请人提供):这是AI51420-01 A支持的扩展我们工作的竞争性更新申请。新生儿独特的自身免疫性卵巢疾病(nAOD)的发病机制已取得重大进展。卵巢ZP3的自身抗体(Ab)导致卵巢免疫复合物的形成。这引发了一种器官特异性自身免疫性疾病,由FcgR+调节,依赖于致病性CD4 T细胞(TD-nAOD)的重新激活。独特的是,nod仅影响新生小鼠,不影响5日龄以上的小鼠;因此,了解新生儿自身免疫倾向是我们的主要目标。我们发现重组酶激活基因(RAG)敲除(KO)小鼠也可诱导严重的nAOD,因此仅先天免疫也足以诱导nAOD (TI-nAOD)。NK细胞在ti - nod中起着多种关键作用。一个重要的观察是NK细胞功能在TI- nod中的个体发生调节。缺乏穿孔素的RAG KO小鼠未发生ti - nod,并且该疾病可通过来自野生型供体的新生而非成年(或第9天)NK细胞恢复。NK在TI-nAOD中的功能也依赖于NKG2D——一种主要的NK细胞激活受体。在AIM 1中,我们将验证Ly49 NK细胞抑制受体表达的晚期个体发生假设,使新生儿NK细胞在新生儿1-5天之间逃避调节,并诱导新生儿卵巢损伤。促炎细胞因子IFNg和FcgR在TI-nAOD和TD-nAOD的发病机制中均发挥了非冗余作用。在AIM 2中,我们将研究RAG KO小鼠ti - nod中IFNg和NK细胞依赖功能的细胞基础。在AIM 3中,我们将研究新生NK细胞和IFNg如何促进野生型小鼠td - nod的新生致病性T细胞反应;特别是确定NK细胞和树突状细胞在这一过程中的相对贡献。最后,NK细胞依赖性的ti - nod很容易被成人CD4+CD25+ Treg抑制,并且它需要IL10。这一发现首次证明Treg抑制任何形式的新生儿免疫反应。在AIM 4中,我们将研究IL10依赖性Treg抑制的细胞机制。同时,通过比较成人和新生儿宿主之间的抑制机制,我们期望对新生儿免疫系统的生理学有新的认识,并进一步阐明新生儿自身免疫性疾病倾向的重要观察。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KENNETH S.K. TUNG其他文献

KENNETH S.K. TUNG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KENNETH S.K. TUNG', 18)}}的其他基金

Research Histology Core
研究组织学核心
  • 批准号:
    7304836
  • 财政年份:
    2006
  • 资助金额:
    $ 37.5万
  • 项目类别:
CORE--CELL SCIENCE
核心--细胞科学
  • 批准号:
    6743300
  • 财政年份:
    2003
  • 资助金额:
    $ 37.5万
  • 项目类别:
Autoimmune Oophoritis: Consequences of Gamete Vaccines
自身免疫性卵巢炎:配子疫苗的后果
  • 批准号:
    6667129
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
CORE--CELL SCIENCE
核心--细胞科学
  • 批准号:
    6590771
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
Antibody induced T cell mediated neonatal autoimmunity
抗体诱导 T 细胞介导的新生儿自身免疫
  • 批准号:
    6825714
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
Regulatory and effector T cells in SLE
SLE 中的调节性 T 细胞和效应性 T 细胞
  • 批准号:
    6663943
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
Antibody induced T cell-mediated neonatal autoimmunity.
抗体诱导 T 细胞介导的新生儿自身免疫。
  • 批准号:
    8206614
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
Autoimmune Oophoritis: Consequences of Gamete Vaccines
自身免疫性卵巢炎:配子疫苗的后果
  • 批准号:
    6847457
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
Antibody induced T cell mediated neonatal autoimmunity
抗体诱导 T 细胞介导的新生儿自身免疫
  • 批准号:
    6983362
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:
Antibody induced T cell mediated neonatal autoimmunity
抗体诱导 T 细胞介导的新生儿自身免疫
  • 批准号:
    6575358
  • 财政年份:
    2002
  • 资助金额:
    $ 37.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了